Literature DB >> 932543

The occurrence of the Tullio phenomenon in congenitally deaf children.

H L Kwee.   

Abstract

One hundred and fifty deaf children between 5 and 16 years old of the 'Rudolf Mees' Institute were investigated in search of the Tullio phenomenon with nystagmus as a criterion. Seventy-six out of those 300 ears were positive. A functioning (calorically excitable) pars superior of the labyrinth was a 'conditio sine qua non' for this reflex. We may assume that deaf ears which show a positive Tullio phenomenon have a labyrinthine pathology of the Mondini-Alexander type and that this symptom is a pathologic one.

Entities:  

Mesh:

Year:  1976        PMID: 932543     DOI: 10.1017/s0022215100082396

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

Review 1.  Efficacy assessment and complications of surgical management for superior semicircular canal dehiscence: a meta-analysis of published interventional studies.

Authors:  Petros V Vlastarakos; Konstantinos Proikas; Evangelia Tavoulari; Dimitrios Kikidis; Paul Maragoudakis; Thomas P Nikolopoulos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-25       Impact factor: 2.503

2.  Observations on the Tullio phenomenon.

Authors:  P Vogel; W Tackmann; F J Schmidt
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

3.  Sound- and pressure-induced vertigo associated with dehiscence of the roof of the superior semicircular canal.

Authors:  A Mong; L A Loevner; D Solomon; D C Bigelow
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

4.  An Osteoma of the Middle Ear Presenting with the Tullio Phenomenon.

Authors:  Rachael Hornigold; Ben J Pearch; Michael J Gleeson
Journal:  Skull Base       Date:  2003-05

5.  The Tullio phenomenon: a neurologically neglected presentation.

Authors:  Diego Kaski; R Davies; L Luxon; A M Bronstein; P Rudge
Journal:  J Neurol       Date:  2011-07-09       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.